Setting. Cannabis preparations have been used as a remedy for thousands of years in
traditional medicine. Clinical use of cannabinoid substances is restricted, due to legal and …

Patients with multiple sclerosis (MS) and spinal cord injury (SCI) commonly sustain central
neuropathic pain (NP) and spasticity. Despite a lack of consistent evidence, cannabis-based …

Objectives: This article attempts to cover pragmatic clinical considerations involved in the
use of cannabinergic medicines in pain practice, including geographical and historical …

Background: One in five individuals live with chronic pain globally, which often co-occurs
with sleep problems, anxiety, depression, and substance use disorders. Although these …

Background: Central neuropathic pain (CNP), pain initiated or caused by a primary lesion or
dysfunction of the central nervous system, occurs in~ 28% of patients with multiple sclerosis …

Cannabis has been used for medicinal purposes for thousands of years. The prohibition of
cannabis in the middle of the 20th century has arrested cannabis research. In recent years …

Central neuropathic pain (CNP) occurs in many multiple sclerosis (MS) patients. The
provision of adequate pain relief to these patients can very difficult. Here we report the first …

Multiple sclerosis (MS) is an inflammatory, demyelinating, autoimmune disease of the CNS.
There are currently a number of disease-modifying medications for MS that modulate or …

Objectives To determine the effects of cannabis, cannabinoids, and their administration
routes on pain and adverse euphoria events. Data sources A systematic search was …

The research of new therapeutic strategies for neuropathic pain represents a major current
priority. Important drawbacks to advance in the development of these therapies are the …